Resources Investment Advisors, Llc. Invitae Corp Transaction History

Resources Investment Advisors, Llc.

$8.43 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$1.71 - $3.61 $3,688 - $7,786	2,157 Added 13.49%	18,152 $33,000
Q3 2022 Nov 08, 2022	BUY	$1.9 - $8.63 $30,390 - $138,036	15,995 New	15,995 $39,000
Q4 2021 Feb 23, 2022	SELL	$14.7 - $28.67 $52,905 - $103,183	-3,599 Reduced 47.71%	3,944 $60,000
Q3 2021 Nov 05, 2021	BUY	$24.31 - $33.6 $28,953 - $40,017	1,191 Added 18.75%	7,543 $214,000
Q2 2021 Aug 09, 2021	SELL	$26.09 - $40.4 $1.05 Million - $1.62 Million	-40,132 Reduced 86.34%	6,352 $214,000
Q1 2021 May 10, 2021	SELL	$33.06 - $56.93 $155,249 - $267,343	-4,696 Reduced 9.18%	46,484 $1.78 Million
Q4 2020 Feb 08, 2021	SELL	$39.09 - $57.4 $35,493 - $52,119	-908 Reduced 1.74%	51,180 $2.14 Million
Q3 2020 Oct 09, 2020	SELL	$28.43 - $44.67 $9,325 - $14,651	-328 Reduced 0.63%	52,088 $2.26 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $112,146 - $290,087	9,577 Added 22.36%	52,416 $1.59 Million
Q1 2020 May 14, 2020	SELL	$7.64 - $27.5 $20,704 - $74,525	-2,710 Reduced 5.95%	42,839 $585,000
Q4 2019 Feb 07, 2020	BUY	$15.02 - $20.57 $225,254 - $308,488	14,997 Added 49.09%	45,549 $734,000
Q3 2019 Nov 08, 2019	SELL	$18.85 - $27.5 $147,030 - $214,500	-7,800 Reduced 20.34%	30,552 $588,000
Q2 2019 Aug 12, 2019	BUY	$17.37 - $26.27 $530,688 - $802,601	30,552 Added 391.69%	38,352 $0
Q1 2019 May 10, 2019	BUY	$10.65 - $25.75 $71,887 - $173,812	6,750 Added 642.86%	7,800 $0
Q4 2018 Feb 12, 2019	BUY	$9.26 - $16.38 $9,723 - $17,199	1,050 New	1,050 $12,000
Q1 2018 May 14, 2018	SELL	$4.69 - $10.05 $6,251 - $13,396	-1,333 Closed	0 $0
Q4 2017 Jan 31, 2018	BUY	$7.86 - $9.99 $10,477 - $13,316	1,333	1,333 $12,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.

Account